叶娜

发布时间：2026-01-31浏览次数：13

  • 1、Discovery of new N-H aporphine derivatives as brain-penetrant Gq-biased 5-HT2C receptor agonists and dual 5-HT2C/5-HT2A receptor agonists,J. Med. Chem.,SCI Q1,2025,Na Ye,最后通讯作者
  • 2、Structure−Activity Relationship Studies of Substituted 2 Phenyl-1,2,4-triazine-3,5(2H,4H) dione Analogues: Development of Potent eEF2K Degraders against Triple-Negative Breast Cancer,J. Med. Chem.,SCI Q1,2024,Na Ye,最后通讯作者
  • 3、Current Emerging Therapeutic Targets and Clinical Investigational Agents for Schizophrenia: Challenges and Opportunities,Med. Res. Rev. ,SCI Q1,2025,Na Ye,第一作者兼共同通讯作者
  • 4、Identification of a novel substrate for eEF2K and the AURKA-SOX8 as the related pathway in TNBC,Adv. Sci.,SCI Q1,2025,Na Ye,共同通讯作者
  • 5、Design and Characterization of a Novel eEF2K Degrader with Potent Therapeutic Efficacy Against Triple-Negative Breast Cancer,Adv. Sci.,SCI Q1,2024,Na Ye,共同通讯作者
  • 6、Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development.,Acta Pharmaceutica Sinica B,SCI Q1,2025,Na Ye,共同通讯作者
  • 7、Macrophage migration inhibitory factor (MIF) in CNS diseases: Functional regulation and potential therapeutic indication,Fundamental Research,ESCI,2024,Na Ye,共同通讯作者
  • 8、Identification of Spiro[chromene-2,4′-piperidine]s as Potent, Selective, and Gq‑Biased 5‑HT2C Receptor Partial Agonists,ACS Med. Chem. Lett.,SCI Q3,2024,Na Ye,最后通讯作者
  • 9、Aporphines: A privileged scaffold in CNS drug discovery,Eur. J. Med. Chem.,SCI Q1,2023,Na Ye,独立通讯作者
  • 10、Targeted to neuronal organelles for CNS drug development,Adv. Drug Deliv. Rev.,SCI Q1,2023,Na Ye,共同第一作者